To understand the effect of erandmool arka in udavartini yonivyapad

Randomised controlled clinical control study to evaluate the efficacy of erandmool arka in udavarta yonivyapad with special refference to primary dysmenorrhoea - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093370

Enrollment

Registered

2025-08-20

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: clinically diagnosed cases of udavarta yonivyapad will be taken for study patient coming with chief complaints of painful menses suffering for at least 3 consecutive menstrual cycles patients with regular menstrual cycles and adequate menstrual flow not associated with any organic reproductive system abnormalities patients ready to participate in study with proper consent

Exclusion criteria

Exclusion criteria: patient having secondary dysmenorrhea patient age below 15 year and above 30 year anc and pnc patient patient on harmonal therapy or using an IUCD patient having any uterine or pelvic pathology patient with history of hypo/hyperthyroidism DM cardiovascular diseases

Design outcomes

Primary

Measure	Time frame
reduce pain before menses and during mensesTimepoint: reduce pain before menses and reduce symptoms of udavartini yonivyapd	—

Secondary

Measure	Time frame
no recurrence of symptoms of udavartini yonivyapadTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Sunil Sadashiv More

Shree Sapatashrhungi Ayurved Mahavidyalay

moresunil263@gmail.com9423934505

Outcome results